America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Want to make money from home? Discover various ways to earn money from home that fit your lifestyle and preferences.
12,971 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
XRP trades around $1.35 after Ripple unveils an AI security upgrade for the XRP Ledger. Yet the market remains subdue...
The Nasdaq has slipped into correction territory, raising questions about the next move. This guide uncovers historic...
The Federal Reserve is anticipated to keep the federal funds rate unchanged as Powell nears the end of his chair tenu...
Can AI truly think, or do we just see clever software? This article dives into the Claude delusion? Richard Dawkins d...
A fintech startup faced backlash after an autonomous AI claimed a non-existent policy, underscoring how deployment ch...
Two popular ETFs both target consumer staples, but their weighting methods lead to distinct risk and return profiles....
Wheaton's Q1 2026 earnings transcript offers clues about margins, cash flow, and future growth in the gold streaming ...
Looking ahead five years, XRP faces a mix of regulatory, market, and adoption factors. This article breaks down scena...
Two popular ETFs compete for your attention: a low-cost, broad staples fund and a concentrated food-and-beverage tilt...
Investors flooded crypto funds with $858M in inflows as lawmakers push a clarity-focused framework for stablecoins. T...
Tron’s TRX surged in 2026, yet fresh on-chain data points to a potential correction risk as price outpaces network ac...